PEAK6 Investments’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,800
Closed -$192K 4150
2024
Q1
$192K Sell
15,800
-49,900
-76% -$724K ﹤0.01% 3087
2023
Q4
$940K Sell
65,700
-34,300
-34% -$329K ﹤0.01% 2138
2023
Q3
$778K Buy
100,000
+72,100
+258% +$785K ﹤0.01% 2022
2023
Q2
$399K Sell
27,900
-36,400
-57% -$518K ﹤0.01% 2367
2023
Q1
$941K Buy
64,300
+60,100
+1,431% +$1.01M ﹤0.01% 1888
2022
Q4
$70.6K Sell
4,200
-4,900
-54% -$84.7K ﹤0.01% 3795
2022
Q3
$135K Sell
9,100
-29,500
-76% -$583K ﹤0.01% 3922
2022
Q2
$692K Buy
38,600
+20,600
+114% +$610K ﹤0.01% 3463
2022
Q1
$679K Sell
18,000
-12,800
-42% -$567K ﹤0.01% 2846
2021
Q4
$1.91M Sell
30,800
-40,000
-56% -$3.03M ﹤0.01% 1946
2021
Q3
$6.06M Buy
70,800
+31,400
+80% +$1.97M 0.01% 1011
2021
Q2
$2.44M Buy
39,400
+11,600
+42% +$590K 0.01% 1692
2021
Q1
$1.35M Sell
27,800
-64,700
-70% -$3.12M ﹤0.01% 2278
2020
Q4
$2.88M Buy
+92,500
New +$2.27M 0.01% 1542
2019
Q4
Sell
-3,200
Closed -$46K 3863
2019
Q3
$46K Buy
+3,200
New +$49.5K ﹤0.01% 3409

Other funds holding OPRX

PEAK6 Investments's OPRX Position: Q4 2023 in Review

PEAK6 Investments sold out of OptimizeRx (OPRX) in Q4 2023, closing a stake of 5,925 shares — an estimated $56.9K sold.

PEAK6 Investments first reported a position in OPRX in Q3 2019 and held it in 10 quarters. The position peaked at $3.37M in Q1 2022. 98 funds tracked by Wall St. Rank hold OPRX as of Q4 2023.

  • PEAK6 Investments reported no remaining OptimizeRx position as of Q4 2023 after selling out during the quarter.
  • PEAK6 Investments sold 5,925 OptimizeRx shares in Q4 2023, an estimated $56.9K.
  • PEAK6 Investments first reported a position in OptimizeRx in Q3 2019 and held it in 10 quarters.
  • PEAK6 Investments's OptimizeRx position peaked at $3.37M in Q1 2022.
  • 98 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2023.

Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.